PainChek Limited (ASX:PCK)

Market Cap	24.04M -73.5%
Revenue (ttm)	3.74M +11.3%
Net Income	-8.94M
EPS	-0.04
Shares Out	209.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,874
Open	0.1200
Previous Close	0.1150
Day's Range	0.1200 - 0.1250
52-Week Range	0.0920 - 1.0500
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About PainChek

PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed...

• Industry: Health Information Services
• Sector: Healthcare
• CEO: Philip Daffas
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PCK

Financial Performance

In fiscal year 2026, PainChek's revenue was 3.74 million, an increase of 11.29% compared to the previous year's 3.36 million. Losses were -8.94 million, 16.5% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error